Skip to main content
. 2018 Sep 4;2018(9):CD013102. doi: 10.1002/14651858.CD013102

Li 2014.

Methods Randomised trial
Participants 117 participants with Chronic Obstructive Pulmonary Disease (COPD) (intervention 58: control 59)
Participants recruited from University hospital
China
Year of study: February 2012 to January 2014
Interventions Intervention group patients received pharmacist‐led individualised education sessions (20 ‐ 30 minutes each session, 5 ‐ 6 sessions) on effective use of respiratory devices, pathophysiology of the disease, interpretation of medical testing and rationale for medication. Medication management records evaluated each participant’s preferences and analysed possible barriers to medication adherence. Telephone calls (4 ‐ 5 sessions) were made at the midpoint between clinic visits. During telephone counselling, the pharmacist asked about the patient’s treatment effects, clarified any misconceptions, explained the nature of any side effects and reminded patients of their next clinical appointment.
Duration: 6 months
Outcomes Health‐related quality of life (HRQoL)
Notes Funding source: Not specified
Conflict of interest: None stated
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk The pharmacists were blinded to the randomisation codes, which were computer‐generated and sealed in envelopes labelled with consecutive numbers.
Allocation concealment (selection bias) Low risk The pharmacists were blinded to the randomisation codes, which were computer‐generated and sealed in envelopes labelled with consecutive numbers.
Blinding of participants and personnel (performance bias) 
 All Outcomes/Outcome 1 High risk Unblinded and with subjective outcomes
Blinding of outcome assessment (detection bias) 
 All Outcomes/Outcome 1 Unclear risk Low risk of bias in detection: surveys completed by participant
Incomplete outcome data (attrition bias) 
 All outcomes High risk Between group attrition < 10%, however, high attrition overall (˜30% lost at 1‐year follow‐up).
Selective reporting (reporting bias) Low risk All major outcomes reported
Other bias Low risk None